Progress on an effective COVID-19 inoculation comes as the virus continues to claim new victims worldwide, while the U.S. fights an uphill battle to contain a surge in confirmed cases. Vaccines remain a key to ending the severe restrictions on public life, which include public mask-wearing and social distancing — all of which have become flashpoints in U.S. political discourse.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Yet the headway on vaccines has made Anthony Fauci, the federal government’s top infectious disease expert, “cautiously optimistic” that a potential vaccine candidate could emerge by late fall, he said on Tuesday. In a recent Yahoo Finance interview, Fauci said the accelerated push was “worth it” despite the inherent risks.” data-reactid=”18″>Yet the headway on vaccines has made Anthony Fauci, the federal government’s top infectious disease expert, “cautiously optimistic” that a potential vaccine candidate could emerge by late fall, he said on Tuesday. In a recent Yahoo Finance interview, Fauci said the accelerated push was “worth it” despite the inherent risks.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="On an earlings call Tuesday, Pfizer’s (PFE) CEO Albert Bourla said they company expects to have some sort of news and completed regulatory review by October 2020. The company had four potential candidates and has advanced one of those — a two-shot 30-microgram dose — into the final phase.” data-reactid=”19″>On an earlings call Tuesday, Pfizer’s (PFE) CEO Albert Bourla said they company expects to have some sort of news and completed regulatory review by October 2020. The company had four potential candidates and has advanced one of those — a two-shot 30-microgram dose — into the final phase.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Moderna (MRNA) also announced its Phase 3 trial yesterday, which it is doing with significant funding and support from the federal government. Johnson & Johnson (JNJ) also announced entering phase 1 of its candidate Monday.” data-reactid=”20″>Moderna (MRNA) also announced its Phase 3 trial yesterday, which it is doing with significant funding and support from the federal government. Johnson & Johnson (JNJ) also announced entering phase 1 of its candidate Monday.
Pfizer executives told investors Tuesday they see the pandemic as a source of recurring revenue with the vaccine becoming a seasonal need, like the flu, and pricing adjusting accordingly. The current price of $19.50 is based on 100 million doses bought at $1.95 billion by the federal government, and is lower than the value the company believes the drug has for society, according to Bourla.
Pricing has been a point of concern for some patient advocacy groups, who believe companies should be providing the vaccine at no-profit costs.
Angela Hwang, global president of biopharmaceuticals at Pfizer, said on Tuesday the company would not offer other countries a lesser price than the U.S., except for poorer countries.
“No country in the developed world will receive (COVID-19 vaccine) doses at a lower price than the U..S.” for similar volume commitments, Hwang added.
Moving to end a ‘dangerous’ dependency
Manufacturing and logistics are proving to be the biggest hurdles the U.S. has to overcome to respond to the coronavirus outbreak.
It’s why the U.S. Health and Human Services Department, through Operation Warp Speed, and the Department of Defense (DoD) have all invested in various strategies to help boost U.S. output.
Shortages of protective gear, testing supplies, glass vials for vaccines and necessary refrigerated transportation for vaccines are all strained amid the pandemic. To date, the executive branch has either funded or used the Defense Protection Act (DPA) to produce N-95 masks and ventilators, and other critical equipment.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="It is also funding the production and research for COVID-19 vaccines. That includes announcements this week to tap Eastman Kodak (KODK) and FUJIFILM (FUJIY) with Texas A&M University for manufacturing.” data-reactid=”29″>It is also funding the production and research for COVID-19 vaccines. That includes announcements this week to tap Eastman Kodak (KODK) and FUJIFILM (FUJIY) with Texas A&M University for manufacturing.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Under the DPA, Kodak has received a $765 million loan to pivot to producing generic drug active ingredients — a product that is largely produced in overseas facilities in India and China.” data-reactid=”30″>Under the DPA, Kodak has received a $765 million loan to pivot to producing generic drug active ingredients — a product that is largely produced in overseas facilities in India and China.
Previously, HHS awarded an up to $812 million grant to startup Phlow Corporation to do the same, in keeping with the Trump Administration’s position that the U.S. is over-reliant on overseas products.
“If we have learned anything from the global pandemic, it is that Americans are dangerously dependent on foreign supply chains for their essential medicines,” said Peter Navarro, White House advisor, in a statement announcing the Kodak loan.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Separately, HHS announced a $265 million contract with FUJIFILM and Texas A&M to help increase the country’s vaccine production capabilities. That includes candidates like Novavax’s (NVAX), which recently announced a separate partnership with FUJIFILM.” data-reactid=”33″>Separately, HHS announced a $265 million contract with FUJIFILM and Texas A&M to help increase the country’s vaccine production capabilities. That includes candidates like Novavax’s (NVAX), which recently announced a separate partnership with FUJIFILM.
Warp Speed has previously given hundreds of millions for key medical material needs to companies like ApiJect, Corning and SiO2 Material. However, other companies are independently pursuing drug production without government money.
Quartic.ai, a startup like Phlow, also recognized the need for domestic production of drug ingredients and began addressing the issue prior to the global pandemic. The company partnered with Bright Path Labs earlier this year to focus on continuous manufacturing of drug ingredients.
Larry Taber, vice president of Life Sciences at Quartic, told Yahoo Finance that Bright Path had been in touch with the White House coronavirus task force about producing 25 ingredients.
“This technology, continuous flow, has been around for a decade and a half, but it has not been well-received by the pharma industry” until a couple of years ago, Taber said.
The technology requires a smaller footprint than traditional batch manufacturing, and would take just a few months to set up. An pharmaceutical veteran, Taber suggested the reason it hasn’t taken off, according to Taber, is because the existing, expensive infrastructure at those companies.
“I’ve taken products outside the U.S. and I know we can bring them back in…and can make them just as competitively,” he said.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Anjalee Khemlani is a reporter at Yahoo Finance. Follow her on Twitter: @AnjKhem” data-reactid=”44″>Anjalee Khemlani is a reporter at Yahoo Finance. Follow her on Twitter: @AnjKhem
More from Anjalee:
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Read the latest financial and business news from Yahoo Finance” data-reactid=”50″>Read the latest financial and business news from Yahoo Finance
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, YouTube.” data-reactid=”51″>Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, YouTube.
COVID-19 in Ottawa: Fast Facts for Aug. 1, 2021 – CTV Edmonton
Good morning. Here is the latest news on COVID-19 and its impact on Ottawa.
- Pfizer and Moderna vaccines now available at all Ottawa vaccination clinics
- Ottawa sees single-digit COVID-19 case numbers on Saturday
- Gee-Gees student-athletes must receive COVID-19 vaccine to compete on teams this season, uOttawa says
COVID-19 by the numbers in Ottawa (Ottawa Public Health data):
- New COVID-19 cases: Four new cases on Saturday
- Total COVID-19 cases: 27,815
- COVID-19 cases per 100,000 (previous seven days): 4.0
- Positivity rate in Ottawa: 0.5 per cent (seven day average)
- Reproduction Number: 1.12 (seven day average)
Who should get a test?
Ottawa Public Health says you can get a COVID-19 test at an assessment centre, care clinic, or community testing site if any of the following apply to you:
- You are showing COVID-19 symptoms;
- You have been exposed to a confirmed case of the virus, as informed by Ottawa Public Health or exposure notification through the COVID Alert app;
- You are a resident or work in a setting that has a COVID-19 outbreak, as identified and informed by Ottawa Public Health;
- You are a resident, a worker or a visitor to long-term care, retirement homes, homeless shelters or other congregate settings (for example: group homes, community supported living, disability-specific communities or congregate settings, short-term rehab, hospices and other shelters);
- You are a person who identifies as First Nations, Inuit or Métis;
- You are a person travelling to work in a remote First Nations, Inuit or Métis community;
- You received a preliminary positive result through rapid testing;
- You are a patient and/or their 1 accompanying escort travelling out of country for medical treatment;
- You are a farm worker;
- You are an educator who cannot access pharmacy-testing; or
- You are in a targeted testing group as outlined in guidance from the Chief Medical Officer of Health.
Long-term care staff, caregivers, volunteers and visitors who are fully immunized against COVID-19 are not required to present a negative COVID-19 test before entering or visiting a long-term care home.
Where to get tested for COVID-19 in Ottawa:
There are several sites for COVID-19 testing in Ottawa. To book an appointment, visit https://www.ottawapublichealth.ca/en/shared-content/assessment-centres.aspx
- The Brewer Ottawa Hospital/CHEO Assessment Centre: Open Monday to Friday 10 a.m. to 5:30 p.m. Saturday and Sunday 8:30 a.m. to 3:30 p.m.
- COVID-19 Drive-Thru Assessment Centre at 300 Coventry Road: Open seven days a week from 10 a.m. to 2 p.m.
- The Moodie Care and Testing Centre: Open Monday to Friday from 8 a.m. to 3:30 p.m.
- The Ray Friel Care and Testing Centre: Open Monday to Friday from 8 a.m. to 3 p.m.
- North Grenville COVID-19 Assessment Centre (Kemptville) – 15 Campus Drive: Open Monday to Friday 9 a.m. to 5 p.m. Sunday from 9 a.m. to 1 p.m.
- Centretown Community Health Centre: Open Monday, Tuesday, Wednesday, Friday from 9 a.m. to 4 p.m.
- Sandy Hill Community Health Centre: Open Monday to Friday from 9 a.m. to 3 pm.
- Somerset West Community Health Centre: Open from 9 a.m. to 4 p.m. Monday to Wednesday, 1 p.m. to 4 p.m. Thursday and 9 a.m. to 2:30 p.m. on Friday
COVID-19 screening tool:
The COVID-19 screening tool for summer camp children and staff. All campers and staff must complete the COVID-19 School and Childcare screening tool daily.
Classic Symptoms: fever, new or worsening cough, shortness of breath
Other symptoms: sore throat, difficulty swallowing, new loss of taste or smell, nausea, vomiting, diarrhea, abdominal pain, pneumonia, new or unexplained runny nose or nasal congestion
Less common symptoms: unexplained fatigue, muscle aches, headache, delirium, chills, red/inflamed eyes, croup
The city of Ottawa says it has an “ample supply” of both Pfizer and Moderna COVID-19 vaccines available if you want to get your COVID-19 vaccine this weekend.
Residents 12 and older are invited to walk-in to Ottawa’s four vaccination clinics to receive a first dose or a second dose of the vaccine.
“Certainly, we’ve done really, really well,” said Anthony Di Monte, Ottawa’s general manager of emergency and protective services.
“We’re seeing a slowing down, that’s why we’re shutting down some of our clinics but we’re leaving four open and anybody who hasn’t had a first dose or wants a second dose can just walk in without an appointment. We have both Moderna and Pfizer available, so I’d encourage anybody please come and get vaccinated.”
Ottawa is currently operating four community clinics. You can drop in between 10 a.m. and 7 p.m. to get a vaccine at the following locations:
- Eva James Community Centre
- Nepean Sportsplex
- Orleans YMCA
- Ottawa City Hall
Ottawa Public Health reported four new cases of COVID-19 in Ottawa on Saturday, one day after the capital saw a double-digit case increase for the first time in three weeks.
No new deaths were reported.
Since the first case of COVID-19 in Ottawa in March 2020, there have been 27,815 laboratory-confirmed cases of COVID-19 in Ottawa, including 593 deaths.
In Ottawa, the five new cases comes one day after Ottawa saw double-digit single day COVID-19 case numbers for the first time since July 4. There were 10 new cases of COVID-19 on Friday and eight new cases on Thursday.
University of Ottawa student-athletes must provide proof they have received at least one dose of the COVID-19 vaccine today to be eligible for the upcoming season..
The university has implemented a mandatory vaccination policy for all Gee-Gees varsity sports for the 2021-22 season.
According to the vaccination policy on the Gee-Gees website, student-athletes are required to have received one dose of the COVID-19 vaccine by Aug. 1, 2021. Vaccination verification information will be required to be submitted as part of the annual medical pre-participation form that is submitted by a student-athlete.
All Gee-Gees student-athletes must receive two doses of the COVID-19 vaccine by Oct. 1.
'It's nice to see everyone's faces again': N.B. no longer under mandatory order, despite concerns from experts – CTV News Atlantic
The Boyce Farmer’s Market, a Fredericton favourite, was a busy spot Saturday morning hours after New Brunswick’s mandatory order was lifted, and with it, all of the province’s COVID-19 restrictions.
Capacity limits no longer apply, and neither do mandatory masks. Many were embracing it.
“This is our happy place. We usually come all the time, and for the longest time it was just a weird, uncomfortable vibe,” said Tyler Wood.
“It’s just amazing to see everyone coming out, seeing the big crowds and seeing people hugging and smiling and just really enjoy the day. It’s just amazing to be back and feel normal.”
The end of the mandatory order also means anyone can visit the province, including Canadians who are unvaccinated. The border checks at the Quebec-New Brunswick border are no longer staffed by the department of public safety.
People can also choose to wear a mask.
Brian MacDonald decided to continue wearing one on his market visit “just to err on the side of caution.”
“I kind of have mixed feelings about New Brunswick opening up to the extent that it is with the Delta variant,” he said. “I hope that the masklessness isn’t a disaster.”
Experts are also expressing their concerns with the decision, warning that it will lead to an increase in cases.
“It does seem to be a little quick,” said Dr. Lisa Barrett, an infectious disease specialist in Halifax.
“It is a bit of an experiment, not as much as Alberta, but a bit of an experiment that didn’t need to happen as quickly as it has. Do I anticipate a massive number of hospitalizations all of a sudden? No, but are there going to be some people who get sick and maybe very sick, who didn’t need to? That’s almost a certainty over the next number of weeks. I’m not certain that that’s okay at this point.”
But Premier Blaine Higgs says he’s confident and comfortable with the decision, even though the province hasn’t reached its 75 per cent vaccination target yet.
Higgs also said his government has made the vaccines very accessible, with mobile and after-hours clinics across the province.
“There are those that have no real reason to be unvaccinated and have chosen not to be, and yes, they’re at risk,” he said.
“They will continue to be at risk, so their fate is in their hands in that sense because the opportunity is there. There’s nothing more I can do. We don’t have a mandatory vaccination policy and I don’t see that coming anytime soon.”
Higgs said he’ll be using his own discretion on wearing a mask.
The end of the mandatory order also effectively stops the need for the all-party COVID-19 cabinet committee.
Since last March, the group saw New Brunswick’s four political parties sit at the same table, making pandemic-related decisions together.
Higgs said meetings could be scheduled if necessary in the future, but for now, no further meetings are planned.
Infectious disease expert calls N.B. plan to lift restrictions 'risky' – HalifaxToday.ca
As of midnight, COVID-19 restrictions will lift in New Brunswick, eliminating mask mandates, provincial border controls and gathering limits in that province.
However, a local infectious disease expert believes the move is coming too soon.
“Clearly we don’t have a lot of cases in the Atlantic right now, but we haven’t quite hit our vaccination targets yet,” said Dalhousie University’s Dr. Lisa Barrett.
“I don’t expect catastrophe, but do I think it’s necessary to get rid of all masks in all places all the time, and to open up with other measures at the same time? It’s probably a little more risky than I was expecting.”
New Brunswick Premier Blaine Higgs had said pandemic restrictions would only lift when 75 per cent of the province’s eligible population had received both doses of COVID-19 vaccine, however as of Friday, only 66.7 per cent of those 12 and older are fully vaccinated.
Barrett says mask requirements are a cheap and easy way to reduce transmission of the virus, and she doesn’t see the advantage of getting rid of them at this stage.
“This really isn’t just a common cold, there are a lot of people who have, even after a mild infection with COVID, some long term side effects,” she told NEWS 95.7 fill-in host Todd Veinotte.
Although Barrett isn’t necessarily expecting cases to surge out of control in our neighbouring province, she said removing restrictions could result in people unnecessarily contracting COVID-19, especially as the more transmissible Delta variant spreads throughout the country.
“We’re not at vaccine targets, vaccines aren’t perfect and we don’t know exactly what the virus does,” she explained. “I just think it’s a little fast, and don’t forget, these experiments, when they go wrong, they’re not cases, they’re people.”
“That means somebody else that’s out there is going to have potentially longer term effects from this or get severely ill,” Barrett added. “So if we have easy things that we can keep doing that still allow us to socialize, and still allow us to go out and still allow the economy to open, why would we get rid of them right away? I don’t understand that part.”
Nova Scotia tracks its vaccination rate differently than New Brunswick. While our neighbours calculate how much of their eligible population has received the shots, we keep count of how many in our overall population have been immunized. COVID-19 vaccines have not yet been approved for those under the age of 12.
As of July 30, 76 per cent of Nova Scotians have had one or more doses, while 62.5 per cent are fully vaccinated.
Our province’s chief medical officer of health has said more restrictions will be lifted here once 75 per cent of our entire population has had both doses of vaccine.
In Nova Scotia, there have been 4,200 cases from March 15 to July 27, 2021. Of those:
- 28 (0.7 per cent) were fully vaccinated
- 235 (5.6 per cent) were partially vaccinated
- 3,937 (93.7 per cent) were unvaccinated
There were 254 people hospitalized. Of those:
- 2 (0.8 per cent) were fully vaccinated
- 28 (11 per cent) were partially vaccinated
- 224 (88.2 per cent) were unvaccinated
Twenty-seven people died. Of those:
- 1 (3.7 per cent) was fully vaccinated
- 3 (11.1 per cent) were partially vaccinated
- 23 (85.2 per cent) were unvaccinated
A ‘safe space for racists’: antisemitism report criticises social media giants – The Guardian
New art gallery exhibit features ceramics inspired by Japanese aesthetics – moosejawtoday.com
UK urges pregnant women to get vaccinated against Delta variant – thedailyguardian.net
Silver investment demand jumped 12% in 2019
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
Iran anticipates renewed protests amid social media shutdown
Health22 hours ago
Majority of COVID-19 cases at large public events were among vaccinated Americans: CDC study – CTV News
Sports18 hours ago
Olympic viewing guide: Andre De Grasse goes for gold, Penny's last shot – CBC.ca
Media13 hours ago
Former Winnipeg Jets forward Mathieu Perreault first media availability with the Habs – Illegal Curve Hockey
Health16 hours ago
A look at COVID-19 reopening plans across the country – BradfordToday
Sports17 hours ago
Andre De Grasse cruises into Olympic 100m semifinal with season-best time – CityNews Toronto
News19 hours ago
How can Canada avoid a fourth wave of COVID-19? Doctors weigh in – CTV News
Media22 hours ago
Why Rabid Fans Are Catching iHeart Media’s Rewatch Podcasts – Forbes
Health21 hours ago
Biosimilar mRNA Vaccines, Part 1: Regulatory Revolution! – The Center for Biosimilars